Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/17050011

Int. J. Cardiol. 2007 Jun 25 119 1 41-7

Download in:

View as

General Info

PMID
17050011